US Stock MarketDetailed Quotes
SYRA Syra Health
- 0.417
- +0.019+4.86%
Close Dec 13 16:00 ET
- 0.410
- -0.007-1.56%
Post 18:21 ET
7.21MMarket Cap-1.66P/E (TTM)
0.428High0.390Low45.66KVolume0.390Open0.397Pre Close18.25KTurnover0.70%Turnover RatioLossP/E (Static)17.31MShares8.37052wk High2.17P/B2.70MFloat Cap0.34452wk Low--Dividend TTM6.49MShs Float8.370Historical High--Div YieldTTM9.64%Amplitude0.344Historical Low0.399Avg Price1Lot Size
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Syra Health Stock Forum
Syra Health Launches Syrenity: An Evidence-Based App for Managing Common Mental Health Conditions
CARMEL, Ind., Dec. 2, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that its flagship mental health app, Syrenity, is now available for direct download by adults 18 years and older. Syrenity leverages a science-driven approach ...
$Infobird Software (IFBD.US)$ Completed $40M acquisition. China stock. Low float. 0 shares LTB✅
$Ocean Power Technologies (OPTT.US)$ Form 4 insider buying. 0 shares LTB✅
$T Stamp (IDAI.US)$ Ran today. Up after hours. Possible catalyst. Low float. 0 shares LTB✅
$Syra Health (SYRA.US)$ Recent Form 4s multiple insider loading. Low fl...
Syra Health to Present at NobleCon20
Syra Health (NASDAQ: SYRA) announced its participation in the Noble Financial Capital Markets 20th Annual Equity Conference (NobleCon20) scheduled for December 3-4 in Boca Raton, Florida. CEO Dr. Deepika Vuppalanchi will present on December 3 at 2:00 p.m. ET, showcasing the company's healthcare solutions focused on mental health crisis, chronic conditions, and child welfare challenges.
The presentation will be followed by a firesid...
As previously disclosed, on August 13, 2024, Syra Health Corp. (the “Company”) received a written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), or 5550(b)(2), or 5550(b)(3) (the “Rules”), since it did not comply with the minimum $2.5 million stockholders’ equity, or $35 million market value of listed securities, or $500,000 of net income from continuing...
Syra Health (NASDAQ: SYRA) reported Q3 2024 financial results with net revenue of $2.3 million, representing 42% growth year-over-year. The company's gross profit margin was 30%, and net loss narrowed to $417,535 ($0.06 per share), showing a 69% reduction compared to Q2 2024. Population Health revenues grew 36% while Healthcare Workforce services increased 54%. The company implemented significant cost-saving measures, reducing operating expenses by 37% quarter...
No comment yet